Autoimmune Hemolytic Anemia as a Complication of Nivolumab Therapy

Publisher： Karger

E-ISSN： 1662-6575|9|3|691-697

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.9, Iss.3, 2016-11, pp. : 691-697

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thymoma with Autoimmune Hemolytic Anemia

By  

Case Reports in Oncology, Vol. 7, Iss. 3, 2014-11 ,pp. : 764-768

Karger

Access to resources Recommend Favorite

The Effect of Erythropoiesis-Stimulating Agents in Patients with Therapy-Refractory Autoimmune Hemolytic Anemia

By  

Transfusion Medicine and Hemotherapy, Vol. 41, Iss. 6, 2014-09 ,pp. : 462-468

Karger

Access to resources Recommend Favorite

Role of Complement in Autoimmune Hemolytic Anemia

By  

Transfusion Medicine and Hemotherapy, Vol. 42, Iss. 5, 2015-09 ,pp. : 303-310

Karger

Access to resources Recommend Favorite

The Clinical Pictures of Autoimmune Hemolytic Anemia

By  

Transfusion Medicine and Hemotherapy, Vol. 42, Iss. 5, 2015-09 ,pp. : 317-324

Karger

Access to resources Recommend Favorite

Successful Treatment of Autoimmune Hemolytic Anemia Associated with Multicentric Castleman Disease by Anti-Interleukin-6 Receptor Antibody (Tocilizumab) Therapy

By  

Acta Haematologica, Vol. 126, Iss. 3, 2011-07 ,pp. : 147-150

Karger

Access to resources Recommend Favorite